Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

Helmut Gadner, Milen Minkov, Nicole Grois, Ulrike Pötschger, Elfriede Thiem, Maurizio Aricò, Itziar Astigarraga, Jorge Braier, Jean Donadieu, Jan-Inge Henter, Gritta Janka-Schaub, Kenneth L. McClain, Sheila Weitzman, Kevin Windebank, Stephan Ladisch

Blood (2013) 121 (25): 5006–5014.

https://doi.org/10.1182/blood-2012-09-455774

Published: 2013

Journal Articles

Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia ( MLL )–rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study

Blood (2010) 116 (15): 2644–2650.

https://doi.org/10.1182/blood-2010-03-273532

Published: 2010

Journal Articles

High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia

Arend von Stackelberg, Reinhard Hartmann, Christoph Bührer, Rüdiger Fengler, Gritta Janka-Schaub, Alfred Reiter, Georg Mann, Kjeld Schmiegelow, Richard Ratei, Thomas Klingebiel, Jörg Ritter, Günter Henze

Blood (2008) 111 (5): 2573–2580.

https://doi.org/10.1182/blood-2007-07-102525

Published: 2008

Journal Articles

Increased TNF/NGF Receptor Expression on BCP-ALL Blasts Carrying the Prognostically Favorable TEL-AML Rearrangement.

Anja Troeger, MD, Ludmila Glouchkova, PhD, Birgit Ackermann, PhD, Gabriele Escherich, MD, Roland Meisel, MD, Hans-Juergen Laws, MD, Helmut Hanenberg, MD, Silja Roettgers, PhD, Gritta Janka-Schaub, MD, Arndt Borkhardt, MD, Ulrich Goebel, MD, Dagmar Dilloo, MD

Blood (2007) 110 (11): 1431.

https://doi.org/10.1182/blood.V110.11.1431.1431

Published: 2007

Journal Articles

Split-Liver Transplantation in a Child with Liver Failure Based on Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from the Same Donor.

Cornelia Nicole Englert, MD, Rainer Ganschow, MD, Matthias Beckmann, MD, Gritta Janka-Schaub, Martin Burdelski

Blood (2006) 108 (11): 5280.

https://doi.org/10.1182/blood.V108.11.5280.5280

Published: 2006

Journal Articles

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia

Blood (2006) 107 (9): 3455–3462.

https://doi.org/10.1182/blood-2005-08-3430

Published: 2006

Journal Articles

CALM-AF10 and HOX11L2 Abnormalities Define Poor Prognostic Subgroups in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Martine van Grotel, MSc, Jules P.P. Meijerink, PhD, Max M. van Noesel, MD, PhD, H. Berna Beverloo, PhD, Anton W. Langerak, PhD, Tim S. Poulsen, PhD, Elisabeth R. van Wering, MD, PhD, E. Gritta Janka-Schaub, MD, PhD, Rob Pieters, MD, PhD

Blood (2005) 106 (11): 3279.

https://doi.org/10.1182/blood.V106.11.3279.3279

Published: 2005

Journal Articles

Upregulation of FLIPs upon CD40 Stimulation - A Novel Inhibititory Mechanism of CD95-Induced Apoptosis in Precursor B-ALL Blasts in Children.

Anja Troeger, Ingo Schmitz, Ludmila Glouchkova, Meinolf Siepermann, Gritta Janka-Schaub, Klaus Schulze-Osthoff, Dagmar Dilloo

Blood (2005) 106 (11): 855.

https://doi.org/10.1182/blood.V106.11.855.855

Published: 2005

Journal Articles

High NGF Receptor Expression on ALL Blasts - A Novel Independent Prognostic Marker Identifying Patients with Favorable Outcome.

Anja Troeger, Ludmila Glouchkova, Hans-Juergen Laws, Helmut Hanenberg, Roland Meisel, Gritta Janka-Schaub, Ulrich Goebel, Dagmar Dilloo

Blood (2005) 106 (11): 1462.

https://doi.org/10.1182/blood.V106.11.1462.1462

Published: 2005

Journal Articles

Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival

Monika Führer, Udo Rampf, Irith Baumann, Andreas Faldum, Charlotte Niemeyer, Gritta Janka-Schaub, Wilhelm Friedrich, Wolfram Ebell, Arndt Borkhardt, Christine Bender-Goetze, for the German/Austrian Aplastic Anemia Working Group

Blood (2005) 106 (6): 2102–2104.

https://doi.org/10.1182/blood-2005-03-0874

Published: 2005

Journal Articles

Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.

Maria Cappellini, MD, Mohamed Bejaoui, MD, Silverio Perrotta, MD, Leyla Agaoglu, MD, Antonios Kattamis, MD, Patricia Giardina, MD, Gritta Janka-Schaub, MD, Herbert Opitz, PhD, Catherine Ressayre-Djaffer, PhD, Daniele Alberti, MD

Blood (2004) 104 (11): 3619.

https://doi.org/10.1182/blood.V104.11.3619.3619

Published: 2004

Journal Articles

Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation

Hermann Heimpel, Volker Anselstetter, Ladislav Chrobak, Jonas Denecke, Beate Einsiedler, Kerstin Gallmeier, Antje Griesshammer, Thorsten Marquardt, Gritta Janka-Schaub, Martina Kron, Elisabeth Kohne

Blood (2003) 102 (13): 4576–4581.

https://doi.org/10.1182/blood-2003-02-0613

Published: 2003

Journal Articles

Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Kathrin Seidemann, Markus Tiemann, Martin Schrappe, Elif Yakisan, Ingrid Simonitsch, Gritta Janka-Schaub, Wolfgang Dörffel, Martin Zimmermann, Georg Mann, Helmut Gadner, Reza Parwaresch, Hansjörg Riehm, Alfred Reiter

Blood (2001) 97 (12): 3699–3706.

https://doi.org/10.1182/blood.V97.12.3699

Published: 2001

Journal Articles

Circumvention of Methotrexate Resistance in Childhood Leukemia Subtypes by Rationally Designed Antifolates

Marianne G. Rots, Rob Pieters, Godefridus J. Peters, Christina H. van Zantwijk, Rob Mauritz, Paul Noordhuis, James C. Willey, Karel Hählen, Ursula Creutzig, Gritta Janka-Schaub, Gertjan J.L. Kaspers, Anjo J.P. Veerman, Gerrit Jansen

Blood (1999) 94 (9): 3121–3128.

https://doi.org/10.1182/blood.V94.9.3121

Published: 1999

NARROW

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia ( MLL )–rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study

High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia

Increased TNF/NGF Receptor Expression on BCP-ALL Blasts Carrying the Prognostically Favorable TEL-AML Rearrangement.

Split-Liver Transplantation in a Child with Liver Failure Based on Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from the Same Donor.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia

CALM-AF10 and HOX11L2 Abnormalities Define Poor Prognostic Subgroups in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Upregulation of FLIPs upon CD40 Stimulation - A Novel Inhibititory Mechanism of CD95-Induced Apoptosis in Precursor B-ALL Blasts in Children.

High NGF Receptor Expression on ALL Blasts - A Novel Independent Prognostic Marker Identifying Patients with Favorable Outcome.

Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival

Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.

Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation

Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Circumvention of Methotrexate Resistance in Childhood Leukemia Subtypes by Rationally Designed Antifolates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only